Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /MOREPENLAB
chevron_leftBack

Morepen Laboratories Ltd.

MOREPENLAB
NSE: MOREPENLAB Delayed
54.52INR 0.1%
0.6377 USD
As of 24 April 2025, Morepen Laboratories Ltd. has a market cap of $349.78M USD, ranking #14042 globally and #900 in India. It ranks #1385 in the Healthcare sector, and #340 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
14042
Country Rank
900
Sector Rank
1385
Industry Rank
340
Key Stats
Market Cap
$349.78MUSD
29.88B INR
Enterprise Value
$331.59MUSD
28.35B INR
Revenue (TTM)
$208.87MUSD
17.84B INR
EBITDA (TTM)
$21.51MUSD
1.84B INR
Net Income (TTM)
$14.75MUSD
1.26B INR
EBITDA Margin
10%
Profit Margin
7.1%
PE Ratio
23.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Sushil Suri open_in_new
Employees
2,152
Founded
1984
Website
morepen.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0.1% 4.9% 9.4% -18% -33% 12%
Upcoming Earnings
Earnings Date
Mon, May 5

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
MOREPENLAB
Morepen Laboratories Ltd
ISIN: INE083A01026
Shares Out.:
547.954M1 Shares Float: 308.682M2
TV:
SA:
YF:
GF:
BA:
MS:
54.52 INR
Bombay Stock Exchange
MIC: XBOM
500288 (MOREPENLAB)
Morepen Laboratories Ltd
ISIN: INE083A01026
TV:
SA:
YF:
GF:
BA:
MS:
52.29 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Morepen Laboratories Ltd.

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometer, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters. It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals. The company offers over the counter products under the Dr. Morepen brand. Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.08B
4.19T INR
14K%
Divi's Laboratories Ltd.
DIVISLAB
$18.37B
1.57T INR
5K%
Cipla Ltd.
CIPLA
$14.45B
1.23T INR
4K%
Torrent Pharmaceuticals Ltd.
TORNTPHARM
$13.21B
1.13T INR
4K%
Mankind Pharma Ltd.
MANKIND
$12.46B
1.06T INR
3K%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
19K%
Merck KGaA
MRK
$59.42B
52.43B EUR
17K%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
13K%
Haleon plc
HLN
$45.57B
34.34B GBP
13K%
Galderma Group AG
GALD
$23.06B
19.13B CHF
6K%